Pappas Ventures

Venture Capital Exempt reporting adviser

Legal name: Pappas Capital, LLC

Durham, NC Website LinkedIn X

AUM

$165.3M
Private fund assets

Private funds

8
Venture Capital 8

Private fund assets

$165.3M
Gross asset value

Employees

—

Last Form D raise

Mar 2022
Most recent fund filing

From SEC Form ADV filing (filed Mar 31, 2026). View on SEC

Investment focus

As listed in industry directories; may be out of date.

Stages
Series A
Geographies
USACanada

People(2)

Owners and executive officers named on the firm's SEC Form ADV.

A
Owner, Amp Family Partnership I
F
Owner, Ford S. Worthy Revocable Trust

Funds(8)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Pappas Life Science Ventures VI, LPVenture Capital$33.3M——Mar 2022Cold
Pv VI CEO Fund, LPVenture Capital$5.9M——Mar 2022Cold
Asia Innovation Ventures, LPVenture Capital$84.0M$200.0M4Sep 2021Cold
A.m. Pappas Life Science Ventures V, LPVenture Capital$9.6M$85.8M29Jan 2019Cold
Pv V CEO Fund, LPVenture Capital$905K$7.0M26Jan 2019Cold
Chiesi Ventures, LPVenture Capital$28.5M———
A. M. Pappas Life Science Ventures IV, LPVenture Capital$3.0M———
Pv IV CEO Fund, LPVenture Capital$148K———

Board seats(1)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

CoLucid Pharmaceuticals
PharmaceuticalsDurham, NCDirector: Arthur Pappas
$37.1M raised
Since Jan 2015
SEC Form D

Regulatory identifiers

CRD number
163346
SEC file number
802-76418
CIK
1320654

Sources